1948 related articles for article (PubMed ID: 9080920)
1. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
[TBL] [Abstract][Full Text] [Related]
2. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
[TBL] [Abstract][Full Text] [Related]
3. The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations.
Lin PH; Appel LJ; Funk K; Craddick S; Chen C; Elmer P; McBurnie MA; Champagne C
J Am Diet Assoc; 2007 Sep; 107(9):1541-51. PubMed ID: 17761231
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Fodor JG; Whitmore B; Leenen F; Larochelle P
CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
[TBL] [Abstract][Full Text] [Related]
5. Dose-response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study.
Cook NR; Kumanyika SK; Cutler JA; Whelton PK;
J Hum Hypertens; 2005 Jan; 19(1):47-54. PubMed ID: 15343354
[TBL] [Abstract][Full Text] [Related]
6. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group.
Arch Intern Med; 1990 Jan; 150(1):153-62. PubMed ID: 2404477
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of hypertension--a randomized controlled trial.
Stamler R; Stamler J; Gosch FC; McDonald AM
Ann Clin Res; 1984; 16 Suppl 43():136-42. PubMed ID: 6398983
[TBL] [Abstract][Full Text] [Related]
8. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
9. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
[TBL] [Abstract][Full Text] [Related]
10. Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women.
Nowson CA; Wattanapenpaiboon N; Pachett A
Nutr Res; 2009 Jan; 29(1):8-18. PubMed ID: 19185772
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
13. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
16. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
17. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.
Sacks FM; Svetkey LP; Vollmer WM; Appel LJ; Bray GA; Harsha D; Obarzanek E; Conlin PR; Miller ER; Simons-Morton DG; Karanja N; Lin PH;
N Engl J Med; 2001 Jan; 344(1):3-10. PubMed ID: 11136953
[TBL] [Abstract][Full Text] [Related]
18. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
[TBL] [Abstract][Full Text] [Related]
20. Reductions in blood pressure following energy restriction for weight loss do not rebound after re-establishment of energy balance in overweight and obese subjects.
Brinkworth GD; Wycherley TP; Noakes M; Clifton PM
Clin Exp Hypertens; 2008 Jul; 30(5):385-96. PubMed ID: 18633761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
